Entopsis , Inc. recalls PCRopsis Support: a) 1 mL, REF 787001; b) 0.25 mL, REF 787002; c) 25 uL, REF 787003; Improves the functionality of PCRo…
- Recall date
- February 21, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1301-2023
- FDA classification
- Class II
- Brand / firm
- Entopsis , Inc.
- Sold / distributed
- Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania
Why it was recalled
Presence of misleading label statements on the product label.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PCRopsis Support: a) 1 mL, REF 787001; b) 0.25 mL, REF 787002; c) 25 uL, REF 787003; Improves the functionality of PCRopsis regents for select applications; nucleic acid extraction from a variety of biological samples
Get recall alerts
Free email alert whenever Entopsis , Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Entopsis , Inc.